Andrew Mullins

Technical Assistant
Andrew Mullins

Andrew joined Dehns in 2016 following the completion of his BSc (Hons) degree in Molecular Cell Biology at the University of York. During his degree he conducted research into the use of CRISPR for targeting stress-related genes in rice and the mutations behind Parkinson’s disease.   

Andrew assists with drafting and prosecution of patent applications for a variety of clients, ranging from universities to large multinational companies. He has gained experience working on patents from a wide variety of areas within life sciences including genome editing techniques, antibodies, diagnostic techniques and pharmaceutical compositions.